Showing results (1-10 of 28) with videos related to
Sort By:
Pageof 3
Journal of Surgical Oncology|December 13, 2021
The evolution of adjuvant/neoadjuvant trials for resectable localized sarcomaMai-Kim Gervais, Dario Callegaro, Alessandro GronchiJournal of Cardiovascular Medicine (Hagerstown, Md.)|February 16, 2010
Pheochromocytoma presenting as inverted Takotsubo cardiomyopathy: a case report and review of the literatureMai-Kim Gervais, André Gagnon, Margaret Henri, et al.Current Oncology (Toronto, Ont.)|December 24, 2025
A Comprehensive Review of Margin Identification Methods in Soft Tissue SarcomaYasmin Osman, Jean-Philippe Dulude, Frédéric Leblond, et al.Annals of Surgical Oncology|August 22, 2024
Histology-Tailored Approach to Soft Tissue SarcomaMai-Kim Gervais, Georges Basile, Jean-Philippe Dulude, et al.Journal of Surgical Oncology|September 11, 2013
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal carcinomatosis arising from colorectal cancerMai-Kim Gervais, Pierre Dubé, Yarrow McConnell, et al.Journal of Surgical Oncology|January 21, 2017
Preoperative MRI of the breast and ipsilateral breast tumor recurrence: Long-term follow upMai-Kim Gervais, Ellen Maki, Dan E Schiller, et al.Journal of Pediatric and Adolescent Gynecology|June 15, 2020
Recurrent High-grade Ovarian Immature Teratoma with Peritoneal DisseminationAlexandre Brind'Amour, Lara De Guerke, Suzanne Fortin, et al.Annals of Surgical Oncology|March 3, 2016
Sentinel Lymph Node Biopsy in Thin Cutaneous Melanoma: A Systematic Review and Meta-AnalysisErin Cordeiro, Mai-Kim Gervais, Prakesh S Shah, et al.Annals of Diagnostic Pathology|November 5, 2022
Tumor bed extending to margins in breast cancer specimens after neoadjuvant chemotherapy: Incidence and clinical significanceMarie-Hélène Ngo, Mai-Kim Gervais, Guy Leblanc, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 25, 2025
Safety of high-dose mitomycin C vs oxaliplatin HIPEC for peritoneal metastasesGiancarlo Sticca, Mikael Soucisse, Maria Abou-Khalil, et al.Pageof 3